Eun Young Choi, MD
Ophthalmology · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Choi’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$7,297
Medicare paid this office $7,297 for 73 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Creation of shunt to improve eye fluid flow using tissue graft | 16 | $2,132 | $133 |
| Short return visit (20+ min) | 28 | $1,431 | $51 |
| Return visit (30+ min) | 13 | $1,143 | $88 |
| Exam of visual field with extended testing | 15 | $595 | $40 |
Who their Medicare patients are
73 Original Medicare patients in 2024. Average age 77 · Women 51% · Health risk score 1.15. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 75% · Chronic kidney disease 41% · Coronary heart disease 32% · Diabetes 22% · Heart failure 21% · Atrial fibrillation 21% · Cancer 16% · Depression 15%.
The office billed $34,694, Medicare allowed $10,048 and paid $7,297; for 100 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Drugs they prescribed that Part D paid
$334,985
Pharmacies billed $334,985 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,755 generic and 947 brand-name prescriptions · $334,985 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lumigan | 90 | $48,243 | $536 |
| Rocklatan | 81 | $48,179 | $595 |
| Rhopressa | 50 | $30,566 | $611 |
| Combigan | 51 | $21,276 | $417 |
| Vyzulta | 24 | $19,926 | $830 |
See all 27 drugs
| Lumigan | 90 | $48,243 | $536 |
| Rocklatan | 81 | $48,179 | $595 |
| Rhopressa | 50 | $30,566 | $611 |
| Combigan | 51 | $21,276 | $417 |
| Vyzulta | 24 | $19,926 | $830 |
| Alphagan P | 41 | $18,207 | $444 |
| Brimonidine | 483 | $18,060 | $37 |
| Latanoprost | 1,033 | $13,295 | $13 |
| Dorzolamide-Timolol | 593 | $11,365 | $19 |
| Brinzolamide | 36 | $8,563 | $238 |
| Prednisolone Acetate | 220 | $8,254 | $38 |
| Travoprost | 42 | $8,172 | $195 |
| Restasis | 11 | $7,942 | $722 |
| Simbrinza | 28 | $7,870 | $281 |
| Dorzolamide-Timolol | 30 | $6,815 | $227 |
| Brimonidine Tartrate-Timolol | 29 | $6,609 | $228 |
| Methazolamide | 12 | $4,254 | $355 |
| Dorzolamide | 218 | $3,866 | $18 |
| Tafluprost | 30 | $3,359 | $112 |
| Timolol Maleate | 253 | $2,730 | $11 |
| Ketorolac Tromethamine | 66 | $692 | $10 |
| Acetazolamide | 12 | $683 | $57 |
| Atropine Sulfate | 25 | $549 | $22 |
| Acetazolamide Er | 15 | $530 | $35 |
| Erythromycin | 35 | $492 | $14 |
| Polymyxin B Sul-Trimethoprim | 50 | $432 | $9 |
| Ciprofloxacin | 17 | $160 | $9 |
Year by year
| 2024 | 3,702 | 1,104 | None | 26% | $334,985 |
| 2023 | 992 | 549 | None | 32% | $104,436 |
| 2022 | 56 | 25 | 0% (0) | 46% | $5,350 |
| 2021 | 67 | 37 | 0% (0) | 55% | $5,158 |
| 2020 | 37 | 18 | None | 57% | $4,850 |
| 2019 | 17 | None | 0% (0) | None | $990 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Rocklatan | 21 | $12,127 | $577 |
| Rhopressa | 16 | $9,883 | $618 |
| Combigan | 16 | $8,342 | $521 |
| Lumigan | 12 | $7,111 | $593 |
| Prednisolone Acetate | 124 | $5,147 | $42 |
| Dorzolamide-Timolol | 146 | $4,984 | $34 |
| Latanoprost | 214 | $4,753 | $22 |
| Brimonidine | 90 | $3,502 | $39 |
| Brimonidine Tartrate-Timolol | 14 | $2,301 | $164 |
| Dorzolamide | 37 | $1,018 | $28 |
| Timolol Maleate | 66 | $752 | $11 |
| Ketorolac Tromethamine | 22 | $559 | $25 |
| Moxifloxacin | 12 | $522 | $43 |
| Polymyxin B Sul-Trimethoprim | 44 | $385 | $9 |
| Atropine Sulfate | 11 | $353 | $32 |
| Ciprofloxacin | 17 | $209 | $12 |
| Ofloxacin | 12 | $167 | $14 |
2022: 1 drug
| Prednisolone Acetate | 12 | $468 | $39 |
2021: 1 drug
| Prednisolone Acetate | 20 | $959 | $48 |
Money from drug and device companies
$286 in 2025
| 2025 | 2 | 9 | None | $286 |
| 2024 | 2 | 4 | None | $240 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alcon Vision | Hydrus Microstent | $268 | 8 payments
|
| Bausch & Lomb Americas | Miebo | $18 | 1 payment
|
See all 9 published payments
| Alcon Vision | Meals · 2025-11-14 | Hydrus Microstent | $144 |
| Alcon Vision | Meals · 2025-06-02 | Hydrus Microstent | $20 |
| Alcon Vision | Meals · 2025-05-06 | Hydrus Microstent | $18 |
| Alcon Vision | Meals · 2025-05-02 | Hydrus Microstent | $14 |
| Alcon Vision | Meals · 2025-03-11 | Hydrus Microstent | $18 |
| Alcon Vision | Meals · 2025-03-05 | Hydrus Microstent | $25 |
| Alcon Vision | Meals · 2025-03-03 | Hydrus Microstent | $11 |
| Alcon Vision | Meals · 2025-02-12 | Hydrus Microstent | $18 |
| Bausch & Lomb Americas | Education · 2025-02-04 | Miebo | $18 |
See earlier years (2024)
2024: $240
| Glaukos | Photrexa | $161 | 1 payment
|
| Alcon Vision | Hydrus Microstent | $79 | 3 payments
|
Professional record
- NPI
- 1396204210
- Trained
- Harvard Medical School, 2019
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 710 Lawrence Expy, Santa Clara, CA, 95051
- NPI first listed
- 2019-03-19
- NPI last updated
- 2024-10-03
- NPI record certified
- 2024-10-03
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.